As of June 17, 2025, Eargo Inc (EAR) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Eargo Inc's Forward P/E to Peers
To better understand Eargo Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Eargo Inc (EAR) | - |
| Axonics Inc (AXNX) | 249.46 |
| Intuitive Surgical Inc (ISRG) | 65.06 |
| AxoGen Inc (AXGN) | 44.37 |
| IDEXX Laboratories Inc (IDXX) | 43.13 |
| Dexcom Inc (DXCM) | 40.55 |
Compared to its competitors, Eargo Inc's Forward P/E is difficult to compare due to insufficient data.